indexado en
  • Base de datos de revistas académicas
  • Abrir puerta J
  • Genamics JournalSeek
  • Claves Académicas
  • DiarioTOCs
  • Infraestructura Nacional de Conocimiento de China (CNKI)
  • Directorio de publicaciones periódicas de Ulrich
  • Biblioteca de revistas electrónicas
  • Búsqueda de referencia
  • Universidad Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Catálogo en línea SWB
  • Biblioteca Virtual de Biología (vifabio)
  • Publón
  • Fundación de Ginebra para la Educación e Investigación Médica
  • pub europeo
  • Google Académico
Comparte esta página
Folleto de diario
Flyer image

Abstracto

Ecchymosis: An Unexpected Side Effect of Montelukast

Gokce Eser*

Montelukast is a leukotriene receptor antagonist which is used to treat allergy and asthma. It acts as a cysteinyl generally well tolerated in clinical practise. Although montelukast is generally considered as a safe drug, it can cause a few adverse drug reactions. In this case study, we will talk about a rare side effect of montelukast that has been reported twice before. The importance of this case report that we mentioned the youngest patient who has ecchymosis due to the use of montelukast treatment. Since there are other hypersensitivity meds that might be more secure (see likewise Warning segment), this medicine ought to be utilized for this condition just when you can't take other sensitivity drugs or they don't function admirably. This prescription should be utilized consistently to be successful. It doesn't work immediately and ought not to be utilized to diminish unexpected asthma tackles or breathing issues. In the event that an asthma assault or abrupt windedness happens, utilize your snappy alleviation inhaler as endorsed. This medication works by obstructing certain characteristic substances (leukotrienes) that may cause or demolish asthma and sensitivities. It helps make breathing simpler by diminishing growing (aggravation) in the aviation routes

Descargo de responsabilidad: este resumen se tradujo utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado